Insider Deck research · News

TEV.F stock news · Teva Pharmaceutical Industries Limited

Latest Teva Pharmaceutical Industries Limited (TEV.F) stock news, headlines, and research context on Insider Deck. Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Market cap $34B.

News desk

Teva Pharmaceutical Industries Limited wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

10 on the wireUpdated within the hour

24/7 Wall St.·Thu, Aug 6, 4:16 AM

AI Electricity Demand: GE Vernova and Eaton Will Capture This Next Wave of Capex

GE Vernova and Eaton both reported blowout quarters fueled by AI power demand, but one company is collecting cash right now while the other is betting on a revenue wave that mostly arrives after 2028. Choosing between them means deciding how much patience you actually have.

Insider Deck desk note

Last$29.20
Day-1.02%
SymbolTEV.F

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on 24/7 Wall St.

Frequently asked questions

What is the latest news on TEV.F?

The TEV.F news desk aggregates recent headlines with research context for Teva Pharmaceutical Industries Limited (Healthcare).

Where can I research TEV.F on Insider Deck?

Teva Pharmaceutical Industries Limited (TEV.F) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.